Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
Clinical trial NCT05689450 · COMPLETED
Trial details
- NCT number
- NCT05689450
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-21
- Primary completion
- 2024-02-02
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.